SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ries L, Eisner M, Kosary C, et al. (National Cancer Institute). SEER Cancer Statistics Review, 1975–2001. Accessed December 1, 2004.
  • 2
    U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002;137: 3446.
  • 3
  • 4
    Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358: 13402.
  • 5
    Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355: 12934.
  • 6
    Ransohoff DF, Harris RP. Lessons from the mammography screening controversy: can we improve the debate? Ann Intern Med. 1997;127: 102934.
  • 7
    Yood M, McCarthy B, Lee N, Jacobsen G, Johnson C. Patterns and characteristics of repeat mammography among women 50 years and older. Cancer Epidemiol Biomarkers Prev. 1999;8: 5959.
  • 8
    Barr J, Franks A, Lee N, Herther P, Schachter M. Factors associated with continued participation in mammography screening. Prev Med. 2001;33: 6617.
  • 9
    Breast Screening Frequency Trial Group. The frequency of breast cancer screening: results from the UKCCCR randomised trial. United Kingdom co-ordinating committee on cancer research. Eur J Cancer. 2002;38: 145864.
  • 10
    Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med. 2000;342: 56471.
  • 11
    Macmillan RD. Screening women with a family history of breast cancer—results from the British familial breast cancer group. Eur J Surg Oncol. 2000;26: 14952.
  • 12
    Moller P, Reis MM, Evans G, et al. Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European familial breast cancer collaborative group. Dis Markers. 1999;15: 17986.
  • 13
    Tilanus-Linthorst MM, Bartels CC, Obdeijn AI, Oudkerk M. Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer. 2000;36: 5149.
  • 14
    Brekelmans CT, Seynaeve C, Bartels CC, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol. 2001;19: 92430.
  • 15
    Smith R, Saslow D, Sawyer K, Burke W, Costanza M, Evans W. American cancer society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003;54: 14169.
  • 16
    Gail M, Rimer B. Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol. 1998;16: 310514.
  • 17
    Gottsche P, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355: 12934.
  • 18
    Humphrey L, Helfand H, Chan B, Woolf S. Breast cancer screening: a summary of the evidence for the U.S. preventive services task force. Ann Intern Med. 2002;137: 34760.
  • 19
    Murabito J, Evans J, Larson M, Kreger B, Splansky G, Freund K. Family breast cancer risk and mammography. Am J Epidemiol. 2001;154: 91623.
  • 20
    Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr. 1994;16: 1716.
  • 21
    Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81: 187986.
  • 22
    Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93: 35866.
  • 23
    Lerman C, Kash K, Stefanke M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr. 1994;16: 1716.
  • 24
    Evans DG, Blair V, Greenhalgh R, Hopwood P, Howell A. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer. 1994;70: 9348.
  • 25
    Evans DG, Lalloo F. Risk assessment and management of high risk familial breast cancer. J Med Genet. 2002;39: 86571.
  • 26
    Diefenbach M, Miller S, Daly M. Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychol. 1999;18: 5326.
  • 27
    Calvocoressi L, Kasl SV, Lee CH, Stolar M, Claus EB, Jones BA. A prospective study of perceived susceptibility to breast cancer and nonadherence to mammography screening guidelines in African American and White women ages 40 to 79 years. Cancer Epidemiol Biomarkers Prev. 2004;13: 2096105.
  • 28
    Vernon S. Risk perception and risk communication for cancer screening behaviors: a review. J Natl Cancer Inst. 1999;25: 10119.
  • 29
    McCaul K, Branstetter A, Schroeder D, Glasgow R. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol. 1996;15: 4239.
  • 30
    Sabatino SA, Burns RB, Davis RB, Phillips RS, Chen YH, McCarthy EP. Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey. Cancer. 2004;100: 233846.
  • 31
    Statistics NCfH (National Center for Health Statistics). Data file documentation: National Health Interview Survey, 2000. 2001.
  • 32
    Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst. 2003;95: 52632.
  • 33
    Constantino J, Gail M, Pee D, Anderson S, Redmond C, Benichou J. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91: 15418.
  • 34
    Anderson S, Ahnn S, Duff K. (NCI). NSABP Breast Cancer Prevention Trial risk assessment program, version 2. NSABP Biostatistical Center Technical Report. August 14, 1992.
  • 35
    Randolph W, Goodwin J, Mahnken J, Freeman J. Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med. 2002;137: 78390.
  • 36
    Rakowski W, Clark MA, Ehrich B. Smoking and cancer screening for women ages 42–75: associations in the 1990–1994 national health interview surveys. Prev Med. 1999;29 (6 part 1): 48795.
  • 37
    Burack RC, George J, Gurney JG. Mammography use among women as a function of age and patient involvement in decision-making. J Am Geriatr Soc. 2000;48: 81721.
  • 38
    Burack RC, Gurney JG, McDaniel AM. Health status and mammography use among older women. J Gen Intern Med. 1998;13: 36672.
  • 39
    Bernstein AB, Thompson GB, Harlan LC. Differences in rates of cancer screening by usual source of medical care. Data from the 1987 national health interview survey. Med Care. 1991;29: 196209.
  • 40
    Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 national health interview survey. Cancer. 2003;97: 152840.
  • 41
    Shah B, Barnwell G, Bieler G. SUDAAN User's Manual, Release 8.0. Research Triangle Park: Research Triangle Park Institute; 2002.
  • 42
    Fisher B, Costantino J, Wickerham D, Redmond C, Kabannah M, Cronin W. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst. 1998;90: 137188.
  • 43
    Rakowski W, Breen N, Meissner H, et al. Prevalence and correlates of repeat mammography among women aged 55–79 in the year 2000 national health interview survey. Prev Med. 2004;39: 110.
  • 44
    Rockhill B, Weinberg CR, Newman B. Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. Am J Epidemiol. 1998;147: 82633.